An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Astellas Pharma Inc11 enrolled

Overview

The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Myasthenia Gravis

Interventions

tacrolimusDRUG

Oral

Eligibility

Sex: ALLMin age: 16 YearsMax age: 64 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinically diagnosed as myasthenia gravis * Those whose MG symptoms are not controlled by the treatment with prednisone Exclusion Criteria: * Those who had undergone thymectomy

Locations (9)

Unnamed facility

Chubu Region, Japan

Unnamed facility

Chugoku Region, Japan

Unnamed facility

Hokkaido Region, Japan

Unnamed facility

Hokuriku Region, Japan

Outcomes

Primary Outcomes

Improvement of clinical symptoms

Time frame: 28 Weeks

Secondary Outcomes

Improvement of daily activity

Time frame: 28 Weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.